Angina: A missed medical opportunity
Best initial management of stable angina starts with correct assessment; lifestyle management, anti-ischaemic drugs and prevention of adverse CV events are key, the role of revascularisation is now confined to specific subgroups
You will learn:
• That angina patients are often mis-assessed in terms of symptom management and risk classification
• The factors that contribute to the development of angina
• The decreasing role for revascularisation in favour of optimal medical therapy for the treatment of angina
• Practical recommendations for selecting anti-ischaemic drugs and for secondary prevention with antithrombotic therapy.
WEBINAR HELD ON 18 MARCH 2021